Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now

About the Role

As a Senior Analyst / Associate on Roivant’s Commercial team, you will be directly responsible for building the functions and capabilities behind Roivant’s commercialization engine. This is a rare chance to shape the commercialization of multiple medicines across a range of indications from the ground up, as Roivant prepares to become the next breakout commercial-stage biotech. This role is built for someone eager to work across the full commercial agenda, including market research, physician and KOL engagement, real-world data analysis, financial modeling, competitive diligence, and other areas, owning end-to-end workstreams and driving recommendations. This is a high-agency position for someone who thrives in a fast-moving and collaborative environment, takes ownership, and runs directly toward hard problems. You will have direct exposure to senior leadership and a front-row seat as your work drives decisions that matter, with real room to grow quickly and take on additional responsibilities.

Responsibilities

Lead commercial workstreams end to end – scoping key questions, structuring analyses, executing the work, and driving to a recommendation
Design and run primary and secondary market research to size markets, map patient journeys, and understand competitive dynamics across a variety of disease areas
Conduct KOL interviews with physicians and market experts, translating qualitative signal into clear implications for commercial strategy and launch planning
Analyze real-world data such as EHR and claims to pressure-test assumptions and quantify commercial opportunities
Build bottom-up revenue forecasts and market models, drawing on standard commercial datasets and pricing/policy sources
Synthesize findings into decision-ready recommendations and presentations that inform strategic decisions prior to and following launches
Manage relationships with internal stakeholders across Roivant and our Vants, as well as external partners, to keep workstreams on track and to a high standard
Contribute to cross-functional problem-solving on the highest-priority questions facing Roivant’s commercial-stage assets

Requirements

Exceptional record of achievement from a top-tier university
3-5 years of experience in a strategy, commercial, or analytical role in life sciences, for example management consulting, a commercial or strategy function at a biopharma or life sciences company, or life sciences-focused investing, banking, or equity research
Direct experience commercializing life sciences products strongly desired — for example, asset launch or a strategy and operations role at a commercial-stage biopharma
Outstanding analytical and problem-solving ability with the range to move fluidly between qualitative and quantitative work
Comfort with data; familiarity with EHR and/or claims data is a plus
Deep experience with Excel, including financial modeling, and PowerPoint
Strong primary-research and stakeholder-engagement skills; credible and clear with senior and expert audiences
Able to lead workstreams independently, navigate ambiguity, and execute at high velocity
Intensely curious, resourceful, and motivated

Skills

Market research
Physician and KOL engagement
Real-world data analysis
Financial modeling
Competitive diligence
Excel
PowerPoint
Primary research
Stakeholder engagement

Location

New York, NY

Work Type

Full-time
Three days per week in-office

Experience Level

Senior Analyst / Associate
3-5 years of experience

Education Level

Top-tier university

Salary/Compensations

$115,000 to $150,000 per year

Benefits

Meaningful equity participation
Comprehensive company-sponsored benefits package

About the Company

Roivant is a biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter.
Roivant advances its pipeline by creating nimble subsidiaries or “Vants” to develop and commercialize medicines and technologies.
Since its inception in 2014, Roivant has achieved the following critical milestones in support of its vision: built over 20 Vants; 12 consecutive positive Phase 3 trials; 8 FDA approvals; 5 successful IPOs; >$6B in capital raised; >$10B in global pharma partnerships and proceeds; and continued pipeline expansion across various modalities and therapeutic areas through in-licensing and acquisition of novel product candidates and technology platforms.
In addition to a robust clinical stage pipeline, Roivant also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.

Equal Opportunity

Roivant Sciences provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws.